
What they do:
Discovering the true signals of disease to power life-changing drugs.
Quick facts:
HQ: St. John's, Canada
This list has 12 startups and was last updated on Oct 15, 2026. 1 of them are hiring right now. Largest teams: Sequence Bio, Future Fields, and Genecis Bio. Latest round: Vimy Pharmaceuticals raised $1.01M (Oct 13, 2026).

What they do:
Discovering the true signals of disease to power life-changing drugs.
Quick facts:
HQ: St. John's, Canada

What they do:
We make unmakeable proteins with radical advanced biomanufacturing.
Quick facts:
HQ: Edmonton, Canada

What they do:
Makes guilt-free plastics from food waste
Quick facts:

What they do:
Biodegradable and carbon neutral textiles, engineered from food waste.
Quick facts:

What they do:
Resistance free pesticides.
Quick facts:

What they do:
Skin patches for generic drug delivery.
Quick facts:

What they do:
We teach your immune system to attack and cure cancer
Quick facts:

What they do:
KemNet supplies reformulated drugs for specific groups of patients.
Quick facts:
Quick facts:
Funding:
$12.6M · Equity · Apr 2026
Quick facts:
HQ: Markham, Canada
Funding:
$3.5M · Equity · Jun 2026
Quick facts:
Funding:
$1.01M · Equity · Oct 2026
Quick facts:
HQ: Richmond, Canada
Funding:
$167K · Equity · Oct 2026
There are 12 startups on this list, last updated on Oct 15, 2026.
1 of them are hiring right now, including Molagri.
By team size: Sequence Bio (52 employees), Future Fields (34 employees), and Genecis Bio (30 employees).
Latest rounds: Vimy Pharmaceuticals — $1.01M Equity (Oct 2026), ARC Medical — $167K Equity (Oct 2026), and Edesa Biotech — $3.5M Equity (Jun 2026).